par Kraft Rovere, Rodrigo 
;Awada, Ahmad
Référence Current opinion in oncology, 20, 3, page (245-248)
Publication Publié, 2008-05
;Awada, Ahmad Référence Current opinion in oncology, 20, 3, page (245-248)
Publication Publié, 2008-05
Article révisé par les pairs
| Titre: |
|
| Auteur: | Kraft Rovere, Rodrigo; Awada, Ahmad |
| Informations sur la publication: | Current opinion in oncology, 20, 3, page (245-248) |
| Statut de publication: | Publié, 2008-05 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | Advanced thyroid cancer |
| Axitinib | |
| Molecular targeted agents | |
| Sorafenib | |
| Sunitinib | |
| MeSH keywords: | Antineoplastic Combined Chemotherapy Protocols -- therapeutic use |
| Doxorubicin -- therapeutic use | |
| Humans | |
| Iodine Compounds -- therapeutic use | |
| Neoplasm Recurrence, Local -- drug therapy | |
| Prognosis | |
| Signal Transduction | |
| Thyroid Neoplasms -- drug therapy | |
| Thyroid Neoplasms -- radiotherapy | |
| Thyroid Neoplasms -- surgery | |
| Thyroidectomy | |
| Note générale: | Journal Article |
| Review | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1040-8746 |
| info:doi/10.1097/CCO.0b013e3282fb289a | |
| info:pii/00001622-200805000-00002 | |
| info:scp/41949131552 | |
| info:pmid/18391621 |
